Abnormal haemoglobins (Beta-Thalassemia) (1 sample/survey – monthly)
[Hemoglobin analízis (ß-Thalassemia) (1 minta/körvizsgálat – havi)]
EPTIS Ringversuch Nr. 1275606 | Letze Änderung 2024-10-08 | URL: https://www.eptis.bam.de/pts1275606 https://www.eptis.bam.de/pts1275606
| Name des Anbieters | |||||||||||||||||||
| Name des Anbieters | QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. | ||||||||||||||||||
| Ansässig in | Hungary | ||||||||||||||||||
| Sprache(n) | English | ||||||||||||||||||
| Anmerkungen | Determination (in %) of different haemoglobin types - abnormal haemoglobins - by HPLC instrument and interpretation of results. It is possible to order the scheme for at least 10 surveys! The whole year's samples (12 pieces) are be sent together in January. Individual evaluation, summary and graphic evaluation, a certificate of participation, and an annual compliance evaluation are issued once a year, after closing the last survey of the year. | ||||||||||||||||||
| Klassifizierung | |||||||||||||||||||
| Produktgruppen |
Health care / medical devices
Human test material |
||||||||||||||||||
| Prüfgebiete |
Medical analysis
|
||||||||||||||||||
| Technische Einzelheiten | |||||||||||||||||||
|
|||||||||||||||||||
| Ringversuchsziele | |||||||||||||||||||
| Zielgruppe des Ringversuchs | In vitro medical laboratories | ||||||||||||||||||
| Relevante Rechtsvorschriften oder Normen | CLSI GP44-A4 – Procedures for Handling and Processing of Blood Specimens for Common Laboratory Tests ILAC_G8:09/2019 – Guidelines on Decision Rules and Statements of Conformity ISO 15189 – Medical laboratories – Requirements for quality and competence ISO/TS20658:2017 – Medical laboratories – Requirements for collection, transport, receipt and handling of samples VIM3 – Vocabulaire International de Métrologie WHO – Guidance on regulations for the Transport of Infectious Substances | ||||||||||||||||||
| Weitere Ziele | validation of testing methods | ||||||||||||||||||
| Teilnehmerzahl | |||||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) | |||||||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | |||||||||||||||||||
| Kosten | |||||||||||||||||||
| Teilnahmegebühr | on demand | ||||||||||||||||||
| Regelmässig durchgeführt | Ja (monthly) | ||||||||||||||||||
| Der Ringversuch wird durchgeführt seit | |||||||||||||||||||
| Kontaktdaten des Anbieters | |||||||||||||||||||
| Anbieter | Kontaktperson | ||||||||||||||||||
|
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
Feketesas u. 19-21. I/7 6720 Szeged Hungary Telefon: +36 30 462 5864 Fax: Web: http://www.qualicont.com/qc/index_en.html http://www.qualicont.com/qc/index_en.html |
Ms. Eszter Mezey
Telefon: +36 30 462 5864 Fax: E-Mail: mail@qualicont.com mail@qualicont.com |
||||||||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für Hungary,
Ms Eszter Mezey.
Ms Eszter Mezey.